0001104659-15-044671.txt : 20150610 0001104659-15-044671.hdr.sgml : 20150610 20150610180120 ACCESSION NUMBER: 0001104659-15-044671 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150608 FILED AS OF DATE: 20150610 DATE AS OF CHANGE: 20150610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peltz Stuart Walter CENTRAL INDEX KEY: 0001578962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 15924372 MAIL ADDRESS: STREET 1: PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 4 1 a4.xml 4 X0306 4 2015-06-08 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001578962 Peltz Stuart Walter C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 1 1 0 0 Chief Executive Officer Common Stock 2015-06-08 4 M 0 60306 10.85 A 60306 D Common Stock 2015-06-08 4 M 0 17170 10.85 A 77476 D Common Stock 2015-06-08 4 S 0 11825 53.81 D 65651 D Common Stock 2015-06-08 4 S 0 36075 54.64 D 29576 D Common Stock 2015-06-08 4 S 0 22300 55.71 D 7276 D Common Stock 2015-06-08 4 S 0 3500 56.40 D 3776 D Common Stock 2015-06-09 4 M 0 26300 10.85 A 30076 D Common Stock 2015-06-09 4 S 0 12500 52.89 D 17576 D Common Stock 2015-06-09 4 S 0 13400 53.64 D 4176 D Common Stock 2015-06-09 4 S 0 400 54.29 D 3776 D Stock Option (Right to Buy) 10.85 2015-06-08 4 M 0 60306 0 D 2023-05-15 Common Stock 60306 110694 D Stock Option (Right to Buy) 10.85 2015-06-08 4 M 0 17170 0 D 2023-05-15 Common Stock 17170 382830 D Stock Option (Right to Buy) 10.85 2015-06-09 4 M 0 26300 0 D 2023-05-15 Common Stock 26300 356530 D Stock Option (Right to Buy) 27.05 2024-01-27 Common Stock 200000 200000 D Stock Option (Right to Buy) 51.00 2025-01-01 Common Stock 300000 300000 D Stock Option (Right to Buy) 218.4 2022-01-10 Common Stock 416 416 D Stock Option (Right to Buy) 490.8 2021-04-27 Common Stock 541 541 D Stock Option (Right to Buy) 1149.6 2020-02-02 Common Stock 583 583 D Stock Option (Right to Buy) 451.2 2019-05-15 Common Stock 583 583 D Stock Option (Right to Buy) 735.6 2018-04-01 Common Stock 293 293 D Stock Option (Right to Buy) 735.6 2018-01-25 Common Stock 708 708 D Stock Option (Right to Buy) 626.4 2017-04-18 Common Stock 322 322 D Stock Option (Right to Buy) 392.4 2016-03-01 Common Stock 136 136 D The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of diversification. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.26 to $54.25 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.26 to $55.18 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.26 to $56.12 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.26 to $56.59 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.23 to $53.21per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.23 to $54.22 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.25 to $54.30 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015. This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016. This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013. Currently exercisable. /s/ Colleen Diver Johnson, attorney-in-fact 2015-06-10